Table 3.

Associations between each outcome and NEET status, crude and adjusted for increasing numbers of potential confounding factors

Outcome Variable	Model
	Crude Effects	Adjusted for Clinical Factorsa	Additionally Adjusted for socio-demographicsb	Additionally adjusted for treatment factorsc	Additionally adjusted for cohort factorsd	Additionally adjusted for service factorse
	OR (95% CI)
Reliable Recovery	0.57 (0.53–0.61)	0.66 (0.62–0.71)	0.66 (0.61–0.71)	0.69 (0.64–0.74)	0.70 (0.65–0.75)	0.67 (0.63–0.73)
Reliable Improvement	0.63 (0.59–0.68)	0.65 (0.60–0.69)	0.64 (0.61–0.71)	0.67 (0.63–0.73)	0.69 (0.64–0.74)	0.68 (0.63–0.73)
Reliable Deterioration	1.45 (1.30–1.63)	1.48 (1.31–1.66)	1.49 (1.32–1.68)	1.44 (1.27–1.63)	1.39 (1.23–1.58)	1.41 (1.25–1.60)
Attrition	1.67 (1.56–1.79)	1.49 (1.39–1.60)	1.47 (1.36–1.58)	1.37 (1.25–1.49)	1.36 (1.25–1.49)	1.31 (1.19–1.43)
	Beta (95% CI), p-value
Engagement	−0.05 (−0.06–−0.04), p < 0.001	−0.04 (−0.05–−0.04), p < 0.001	−0.04 (−0.05– −0.04), p < 0.001	−0.03 (−0.04– −0.03), p < 0.001	−0.03 (−0.04–−0.03), p < 0.001	−0.03 (−0.04–−0.03), p < 0.001

^aAdjusted for pre-treatment PHQ-9 scores, GAD-7 scores, W&SAS items 2-5 scores, IAPT phobias scale item scores, psychotropic medication, and diagnosis.

^bAdditionally adjusted for gender, age, ethnicity, IMD decile, and long-term conditions.

^cAdditionally adjusted for the number of LI sessions, the number of HI sessions, days between referral and assessment, days between assessment and starting treatment.

^dAdditionally adjusted for year and month of first appointment.

^eAdditionally adjusted for service data came from.